Official Translational Research Institute Launch
Dr Patrick Ling
The world-class facility brings together some of Queensland's best medical researchers from Queensland University of Technology, University of Queensland, Mater Medical Research Institute, and the Princess Alexandra Hospital.
Queensland Premier Anna Bligh announced the official start of the project, and spoke of the significance of having research, testing, drug development, and drug production all under the one roof.
The TRI is set to open in 2012, and has received funding from the Australian Government, Queensland Government, The Atlantic Philanthropies, QUT and UQ.
Aus-CanPCRA member Dr Patrick (Ming Tat) Ling's research will be a centrepiece of the $354 million Institute when it opens in Brisbane, is leading a team of researchers who have identified a particular constituent of vitamin E, known as tocotrienol (T3), which can inhibit the growth of prostate tumours.
Dr Ling's research has been funded by Davos Life Science in Singapore, who recently awarded him a further $128,000 to undertake a one-year study of the long-term effectiveness of T3 to prevent the recurrence of treated prostate cancer tumours.
